Welcome to PathPulse, the Digital Diagnostic podcast! In this episode, "Precision at the Point of Diagnosis: The Role of Genomic Tests in Personalized Pathology," host James Thackeray is joined by Jay Jhaveri to explore the transformative impact of genomic testing on modern diagnostics.

Jay Jhaveri is the Senior Director at Pacific Edge Cancer Diagnostics. His extensive background uniquely positions him at the intersection of clinical practice and diagnostic innovation. Jay earned his MD in 2006 and pursued a rich clinical and research path including general surgery, a fellowship in prostate cancer outcomes research at Weill Cornell, a men's health fellowship, a Master's of Public Health in epidemiology and biostatistics, a urology residency at UC Irvine, and a fellowship in clinical minimally invasive urologic surgery. He also became an associate-certified professional coder. Jay transitioned from clinical medicine to the industry, applying his deep medical knowledge to roles in medical affairs, clinical development, health economics, and outcomes research.

This episode delves into the shift from traditional pathology, which primarily focuses on the morphological examination of tissues, to precision pathology, which leverages genomic and transcriptomic signatures for personalized diagnoses. Jay Jhaveri explains how understanding specific genetic mutations and biomarkers can lead to more accurate risk stratification and tailored patient management. Tune in to understand how genomic insights are reshaping the landscape of pathology and patient care.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

In this episode, Dr. Matthew O. Leavitt takes us through his digital pathology journey and what he's learned along the way.

Dr. Matthew O. Leavitt is a Stanford-trained pathologist and a visionary leader in digital pathology. His journey began in the early 2000s when, as Department Chair at a major Utah-based medical center, he recognized the immense potential of digital pathology to transform diagnostics. In 2014, he founded Lumea, a pioneering digital pathology company designed to enhance lab workflow efficiency and drive standardization.

Building on this foundation, Dr. Leavitt launched PathNet in 2020, a groundbreaking hub-and-spoke virtual pathology practice that now delivers digital diagnostic services to underserved patient populations across 35 states. His latest endeavor focuses on unlocking the power of patient health data through the DDx Foundation, where he is working to improve cross-sector data exchange between technology, life sciences, and healthcare organizations.

A relentless innovator, Dr. Leavitt continues to push the boundaries of digital pathology, driving advancements that enhance diagnostic accuracy, accessibility, and patient care.

Sponsored by the Digital Diagnostic Summit and Lumea.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

Westley (Wes) J. Bernhardt is a driven, entrepreneurial senior operations executive with a proven track record of transforming organizational performance, enhancing efficiencies, and driving profitability across diverse industries. In his current role as Managing Partner of OnePath Diagnostics, Wes leads with a focus on operational excellence and strategic growth. He applies his extensive expertise to create highly efficient organizations, build loyal and collaborative teams, and foster positive, results-driven cultures.

Previously, Wes served as Vice President of Operations for Aurora Diagnostics, the largest independent anatomic pathology laboratory in the U.S. Wes managed a team of 400, including 30 doctors and four general managers, across six laboratories. He led numerous transformative initiatives, including laboratory mergers, technology conversions, physician recruitment, and market expansions.

A proven leader in operations, Wes continues to deliver innovative solutions that drive growth, operational excellence, and profitability, helping organizations adapt and thrive in rapidly changing industries.

Join us to hear how OnePath Diagnostics found success and accelerated their growth with digital pathology.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

Welcome to PathPulse: Pathology Innovators in Action. Today, we’re honored to host Dr. Liron Pantanowitz, the Maud L. Menten Professor and Chair of the Department of Pathology at UPMC and the University of Pittsburgh. With a distinguished career spanning over two decades, Dr. Pantanowitz is a pioneer in digital and computational pathology. From co-founding the Journal of Pathology Informatics to advancing groundbreaking guidelines in whole slide imaging and AI applications, his contributions have shaped the field. Beyond his informatics expertise, he’s a globally recognized cytopathologist and past president of both the Digital Pathology Association and the American Society of Cytopathology. He has also been awarded recognition for multiple years on The Pathologist Power List. Get ready for an insightful conversation about shifting mindsets towards digital pathology with one of pathology's leading voices.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

In this episode of PathPulse: Pathology Innovators in Action, we were thrilled to welcome neuropathologist Margaret Flanagan, MD, talk with us about what is missing from digital pathology, highlighting spatial transcriptomics, multi-omics, and more. Margaret Flanagan, is an Associate Professor and Endowed Chair of the Baptist Health Foundation of San Antonio's Distinguished Chair in Alzheimer and Neurodegenerative Diseases. She was also just featured on The Pathologist's 2024 Power List as an Idol of Innovation! Her work focuses on understanding the mechanisms underlying dementia to advance diagnostic and therapeutic solutions.

Currently, Dr. Flanagan serves as Neuropathology Core Co-Leader for the South Texas ADRC, Co-Director of the Biggs Institute Brain Bank, and Director of the Nun Study on Aging and Alzheimer’s Disease. Her multidisciplinary laboratory integrates molecular platforms, biomarker development, biostatistics, and epidemiology to explore dementia mechanisms and develop biomarkers for early neurodegeneration detection. She is also a founding member of the National Digital Pathology Working Group and leads a 24+ month webinar series in collaboration with the National Alzheimer’s Coordinating Center.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

In this episode of PathPulse: Pathology Innovators in Action, James Thackeray, head of the Digital Diagnostic Summit board, interviews Andy Ivie, a digital pathology software expert. Andy Ivie started his career in digital pathology development in 2013, working as Director of Software Research & Development for Leavitt Medical, Inc. The company was later renamed Lumea, and he now serves as its Chief Technology Officer.

Tune in to listen to his insights on significant changes in the last 12 years with digital pathology, the rationale of going digital (other than AI), artificial intelligence, and recent exciting developments in digital pathology -- all from a behind-the-scenes software perspective.

James and Andy also discuss Andy's featured article in the Digital Diagnostic Digest: Top 5 Reasons to Adopt Digital Pathology Today (Spoiler: AI Isn’t One of Them). Subscribe to the digest to read the full article and more here: https://lumeadigital.com/digital-diagnostic-digest/

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

In this newest episode of PathPulse, Jake Brown interviews our esteemed guest Dr. Lewis Hassell. Dr. Hassell is a pathologist and Director of Anatomic Pathology at The University of Oklahoma Health Sciences Center. He leads the Open Pathology Education Network (OPEN), which provides digital education to pathologists in underserved regions, with pilot programs launched in Vietnam. Dr. Hassell has a strong focus on resident education and the use of digital pathology for both training and global care. He completed his residency in Clinical and Anatomic Pathology at Massachusetts General Hospital and a fellowship in Nuclear Medicine at UCSF. He is board-certified in Cytopathology and Anatomic/Clinical Pathology.

Tune in to listen to his insights and hear about his work in digital pathology to help solve some of the access to care issues that we face, both domestically as well as internationally, largely focused on the supply and quality of pathologists.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.

In this newest episode of PathPulse, James Thackeray, Executive Board Member of the Digital Diagnostic Summit, interviews two guests from KLAS Research: Eder Lagemann, Global Director of Digital Pathology, and Sidney Tate, Insights Director. Together, they discuss key emerging trends in digital pathology.

Discover how digital pathology adoption has measured up against radiology, the contrasting adoption rates between the U.S. and Europe, and the primary factors driving this shift across different groups. Gain insights into what’s propelling industry growth and what must change to accelerate widespread adoption.

KLAS is a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider's voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services, and medical equipment to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Learn more at klasresearch.com.

Submit questions for our future recordings here: https://lumeadigital.com/ask-a-pathologist-podcast/

Sponsored by the Digital Diagnostic Summit and Lumea.